Inogen (INGN) Stock Price, News & Analysis

Company Overview

Inogen, Inc. is a medical technology company that develops, manufactures and distributes oxygen therapy products for people with chronic respiratory conditions. Its offerings are designed to provide supplemental oxygen outside traditional clinical settings, including at home and while traveling.

The company is best known for its Inogen One family of portable oxygen concentrators, which extract oxygen from ambient air and deliver it to patients without requiring refillable oxygen tanks. Inogen also offers stationary oxygen concentrators, accessories and related services, including equipment support and rental programs.

Founded in 2001 and headquartered in Goleta, California, Inogen serves customers through direct-to-consumer sales, health care providers and distributors. The company primarily operates in the United States and also reaches selected international markets through commercial partners and distribution channels.

Key Stats

• Today's Range: $5.33 to $5.38
• 50-Day Range: $5.09 to $6.92
• 52-Week Range: $5.05 to $9.13
• Volume: 28,590 shs
• Average Volume: 292,144 shs
• Market Capitalization: $142.62 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Moderate Buy

Inogen Stock Analysis - MarketRank™

Inogen scored higher than 21% of companies evaluated by MarketBeat, and ranked 800th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Inogen has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Inogen has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Inogen is -5.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Inogen is -5.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Inogen has a P/B Ratio of 0.76. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

5.28% of the float of Inogen has been sold short.

Short Interest Ratio / Days to Cover

Inogen has a short interest ratio ("days to cover") of 5.14.

Change versus previous month

Short interest in Inogen has recently decreased by 6.59%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Inogen does not currently pay a dividend.

Dividend Growth

Inogen does not have a long track record of dividend growth.

News and Social Media

• Score: 1.7 / 5
• News Sentiment: 0.64

News Sentiment

Inogen has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Inogen this week, compared to 2 articles on an average week.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Inogen insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $72,191.00 in company stock.

Percentage Held by Insiders

2.50% of the stock of Inogen is held by insiders.

Percentage Held by Institutions

89.94% of the stock of Inogen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 9/28/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:INGN
• CIK: 1294133
• Web: www.inogen.com
• Phone: (805) 562-0500
• Fax: N/A
• Employees: 753
• Year Founded: 2001

Profitability

• EPS (Trailing Twelve Months): ($0.90)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$22.75 million
• Net Margins: -6.94%
• Pretax Margin: -7.14%
• Return on Equity: -13.17%
• Return on Assets: -8.36%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.74
• Quick Ratio: 2.34

Sales & Book Value

• Annual Sales: $354.30 million
• Price / Sales: 0.40
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $7.08 per share
• Price / Book: 0.76

Miscellaneous

• Outstanding Shares: 26,538,000
• Free Float: 25,875,000
• Market Cap: $142.24 million
• Optionable: Optionable
• Beta: 1.57